查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1671160

瘧疾疫苗的全球市場:市場規模·佔有率·趨勢，產業分析 (疫苗類別·各給藥途徑·目標人口·疫苗接種計劃·各開發階段·各地區)，未來預測 (2025年～2034年)

Malaria Vaccines Market Size, Share, Trends, Industry Analysis Report: By Vaccine Type, Administration Route, Target Population, Immunization Schedule, Development Stage, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球瘧疾疫苗市場預計到 2034 年將達到 16.1987 億美元。該報告提供了有關當前市場動態的詳細見解，並對未來市場的成長進行了分析。

瘧疾是一種由原生動物引起的嚴重且危及生命的疾病，透過受感染的蚊子叮咬在人與人之間傳播。這種由蚊子傳播的疾病會導致兒童和成人患上嚴重疾病。孕婦和兒童特別容易感染瘧疾引起的發燒。預防這種疾病的各種措施包括使用防蟲網和噴灑殺蟲劑。然而，目前的研究發現，昆蟲對殺蟲劑具有免疫力，殺蟲劑對人體有害，抗瘧藥物的療效也正在降低。為了應對這些挑戰，研究人員和製藥公司正在致力於開發瘧疾疫苗作為替代預防方法。

有幾個因素推動了瘧疾疫苗市場的成長，包括全球瘧疾發病率的上升以及全球製藥公司推出低成本瘧疾疫苗。人們對疾病影響的認識不斷提高以及正在進行的研究和開發 (R&D) 努力進一步推動了市場的發展。

政府機構和私人組織加強開發力度，解決一些瘧疾流行的發展中國家薄弱的供應鏈和分銷問題，預計將促進瘧疾疫苗的普及。對增加疫苗接種計劃和開發創新疫苗技術的重視預計將在未來幾年為瘧疾疫苗市場提供許多市場機會。

瘧疾疫苗市場：概述

根據疫苗類型，RTS,S/AS01 部門預計將在 2024 年佔據瘧疾疫苗市場收入的最大佔有率，這得益於大量臨床研究和試驗證明了 RTS,S/AS01 疫苗的有效性，以及該疫苗在非洲國家的推出。

根據給藥途徑，肌肉注射在 2024 年佔據了瘧疾疫苗市場的主導佔有率，因為它是瘧疾疫苗最廣泛使用的給藥途徑，包括 R21/Matrix-M 和 RTS,S/AS01。

由於大型製藥公司大力投資瘧疾疫苗開發計劃，以及推出支持瘧疾疫苗研發計劃的有利政府法規，北美在 2024 年引領了瘧疾疫苗市場。

預計中東和非洲瘧疾疫苗市場將在 2025 年至 2034 年間實現顯著的複合年增長率。這是由於人們更加重視改善衛生基礎設施，加強政府與私人組織之間的合作，以開發具有成本效益的瘧疾疫苗。

Instituto Butantan、默克、PATH、葛蘭素史克、Vaxart、Biovac、輝瑞、Inovio Pharmaceuticals、Bharat Biotech、牛津大學、Intellia Therapeutics、強生、Sanaria 和武田製藥是該市場的一些主要參與者。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球瘧疾疫苗市場洞察

  • 市場概述
  • 瘧疾疫苗的市場動態
    • 促進因素和機會
      • 低收入國家瘧疾發生率不斷上升
      • 增加資金和投資
    • 阻礙因素和挑戰
      • 藥物開發和分銷成本高昂
  • 大環境分析
  • 瘧疾疫苗市場應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球瘧疾疫苗市場:疫苗類別

  • 主要的分析結果
  • 簡介
  • 秘魯
  • RTS,S/AS01
  • R21/矩陣M

第6章 全球瘧疾疫苗市場:各給藥途徑

  • 主要的分析結果
  • 簡介
  • 皮下
  • 肌肉內

第7章 全球瘧疾疫苗市場:目標人口

  • 主要的分析結果
  • 簡介
  • 流行地區旅遊者
  • 孕婦
  • 不滿5歲的兒童

第8章 全球瘧疾疫苗市場:疫苗接種計劃

  • 主要的分析結果
  • 簡介
  • 單回接種
  • 多回接種
  • 追加接種

第9章 全球瘧疾疫苗市場:各開發階段

  • 主要的分析結果
  • 簡介
  • 前臨床
  • 臨床試驗

第10章 全球瘧疾疫苗市場:各地區

  • 主要的分析結果
  • 簡介
    • 瘧疾疫苗市場評估:各地區 (2020～2034年)
  • 北美
    • 北美:疫苗類別 (2020～2034年)
    • 北美:各給藥途徑 (2020～2034年)
    • 北美:目標人口 (2020～2034年)
    • 北美:疫苗接種計劃 (2020～2034年)
    • 北美:各開發階段 (2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:疫苗類別 (2020～2034年)
    • 歐洲:各給藥途徑 (2020～2034年)
    • 歐洲:目標人口 (2020～2034年)
    • 歐洲:疫苗接種計劃 (2020～2034年)
    • 歐洲:各開發階段 (2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:疫苗類別 (2020～2034年)
    • 亞太地區:各給藥途徑 (2020～2034年)
    • 亞太地區:目標人口 (2020～2034年)
    • 亞太地區:疫苗接種計劃 (2020～2034年)
    • 亞太地區:各開發階段 (2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:疫苗類別 (2020～2034年)
    • 中東·非洲:各給藥途徑 (2020～2034年)
    • 中東·非洲:目標人口 (2020～2034年)
    • 中東·非洲:疫苗接種計劃 (2020～2034年)
    • 中東·非洲:各開發階段 (2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:疫苗類別 (2020～2034年)
    • 南美:各給藥途徑 (2020～2034年)
    • 南美:目標人口 (2020～2034年)
    • 南美:疫苗接種計劃 (2020～2034年)
    • 南美:各開發階段 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第11章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第12章 企業簡介

  • Instituto Butantan
  • Merck
  • PATH
  • GSK
  • Vaxart
  • Biovac
  • Pfizer
  • Inovio Pharmaceuticals
  • Bharat Biotech
  • University of Oxford
  • Intellia Therapeutics
  • Johnson & Johnson
  • Sanaria
  • Takeda Pharmaceutical Company
Product Code: PM1525

The global malaria vaccines market size is expected to reach USD 1,619.87 million by 2034, according to a new study by Polaris Market Research. The report "Malaria Vaccines Market Size, Share, Trends, Industry Analysis Report: By Vaccine Type, Administration Route (Subcutaneous and Intramuscular), Target Population, Immunization Schedule, Development Stage, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Malaria is a serious, life-threatening disease caused by Plasmodium parasite, which is transmitted from human to human by the bite of infected mosquitoes. This mosquito-borne illness causes severe disease in kids and adults. Pregnant women and children are particularly vulnerable to the fever caused by malaria. Various precautions to control the disease include the use of insect nets and spraying of pesticides. However, current research studies have shown that insects are immune to pesticides, pesticides have harmful effects on human beings, and malaria fever is becoming immune to medications. In response to these challenges, researchers and pharmaceutical companies have been working on the development of malaria vaccines as an alternative method of prevention.

Several factors, such as the rising incidence of malaria worldwide and the introduction of low-cost malaria vaccines by pharma companies globally, are driving the malaria vaccines market growth. Rising awareness about the disease's consequences and ongoing research and development (R&D) initiatives are further supporting the market development.

Growing efforts by government and private organizations to address the issues of weak supply chains and distribution networks in some malaria-endemic developing countries are expected to boost the adoption of malaria vaccines. Rising inoculation programs and emphasis on the development of innovative vaccine technologies are expected to provide several malaria vaccines market opportunities in the coming years.

Key Highlights of Malaria Vaccines Market Report

Based on vaccine type, the RTS,S/AS01 segment held the largest share of the malaria vaccines market revenue in 2024, owing to the extensive clinical research and trials demonstrating the efficacy of RTS, S/AS01 vaccines, and their rollout in various African countries.

By administration route, the intramuscular segment led the malaria vaccines market share in 2024 as intramuscular is the most widely used route for administrating malaria vaccines, including R21/Matrix-M and RTS,S/AS01.

North America led the market for malaria vaccines in 2024, driven by the strong presence of leading pharma companies with significant investments in malaria vaccine development programs and the introduction of favorable government regulations supporting malaria vaccine R&D initiatives.

The Middle East & Africa malaria vaccines market is projected to witness a significant CAGR from 2025 to 2034, driven by the rising focus on improving healthcare infrastructure and enhanced collaborations between government and private organizations to develop cost-effective malaria vaccines.

Instituto Butantan, Merck, PATH, GSK, Vaxart, Biovac, Pfizer, Inovio Pharmaceuticals, Bharat Biotech, University of Oxford, Intellia Therapeutics, Johnson & Johnson, Sanaria, and Takeda Pharmaceutical Company are a few of the key players in the market.

Polaris Market Research has segmented the malaria vaccines market research report on the basis of vaccine type, administration route, target population, immunization schedule, development stage, and region:

By Vaccine Type Outlook (Revenue - USD Million, 2020-2034)

  • PfSPZ
  • RTS,S/AS01
  • R21/Matrix-M

By Administration Route Outlook (Revenue - USD Million, 2020-2034)

  • Subcutaneous
  • Intramuscular

By Target Population Outlook (Revenue - USD Million, 2020-2034)

  • Travelers to Endemic Areas
  • Pregnant Women
  • Children under 5 Years

By Immunization Schedule Outlook (Revenue - USD Million, 2020-2034)

  • Single Dose
  • Multi-Dose
  • Booster Doses

By Development Stage Outlook (Revenue - USD Million, 2020-2034)

  • Preclinical
  • Clinical Trials

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Malaria Vaccines Market Insights

  • 4.1. Malaria Vaccines Market - Application Snapshot
  • 4.2. Malaria Vaccines Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Prevalence of Malaria in Low-Income Countries
      • 4.2.1.2. Increasing Funding and Investment
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Drug Development and Distribution
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry Among Existing Firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Malaria Vaccines Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Malaria Vaccines Market, by Vaccine Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • 5.3. PfSPZ
    • 5.3.1. Global Malaria Vaccines Market, by PfSPZ, by Region, 2020-2034 (USD Million)
  • 5.4. RTS,S/AS01
    • 5.4.1. Global Malaria Vaccines Market, by RTS,S/AS01, by Region, 2020-2034 (USD Million)
  • 5.5. R21/Matrix-M
    • 5.5.1. Global Malaria Vaccines Market, by R21/Matrix-M, by Region, 2020-2034 (USD Million)

6. Global Malaria Vaccines Market, by Administration Route

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • 6.3. Subcutaneous
    • 6.3.1. Global Malaria Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Million)
  • 6.4. Intramuscular
    • 6.4.1. Global Malaria Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Million)

7. Global Malaria Vaccines Market, by Target Population

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • 7.3. Travelers to Endemic Areas
    • 7.3.1. Global Malaria Vaccines Market, by Travelers to Endemic Areas, by Region, 2020-2034 (USD Million)
  • 7.4. Pregnant Women
    • 7.4.1. Global Malaria Vaccines Market, by Pregnant Women, by Region, 2020-2034 (USD Million)
  • 7.5. Children Under 5 years
    • 7.5.1. Global Malaria Vaccines Market, by Children Under 5 years, by Region, 2020-2034 (USD Million)

8. Global Malaria Vaccines Market, by Immunization Schedule

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • 8.3. Single Dose
    • 8.3.1. Global Malaria Vaccines Market, by Single Dose, by Region, 2020-2034 (USD Million)
  • 8.4. Multi-Dose
    • 8.4.1. Global Malaria Vaccines Market, by Multi-Dose, by Region, 2020-2034 (USD Million)
  • 8.5. Booster Doses
    • 8.5.1. Global Malaria Vaccines Market, by Booster Doses, by Region, 2020-2034 (USD Million)

9. Global Malaria Vaccines Market, by Development Stage

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 9.3. Preclinical
    • 9.3.1. Global Malaria Vaccines Market, by Preclinical, by Region, 2020-2034 (USD Million)
  • 9.4. Clinical Trials
    • 9.4.1. Global Malaria Vaccines Market, by Clinical Trials, by Region, 2020-2034 (USD Million)

10. Global Malaria Vaccines Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Malaria Vaccines Market Assessment, by Geography, 2020-2034 (USD Million)
  • 10.3. Malaria Vaccines Market - North America
    • 10.3.1. North America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.3.2. North America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.3.3. North America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.3.4. North America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.3.5. North America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.3.6. Malaria Vaccines Market - US
      • 10.3.6.1. US: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.3.6.2. US: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.3.6.3. US: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.3.6.4. US: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.3.6.5. US: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.3.7. Malaria Vaccines Market - Canada
      • 10.3.7.1. Canada: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.3.7.2. Canada: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.3.7.3. Canada: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.3.7.4. Canada: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.3.7.5. Canada: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.4. Malaria Vaccines Market - Europe
    • 10.4.1. Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.4.2. Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.4.3. Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.4.4. Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.4.5. Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.6. Malaria Vaccines Market - UK
      • 10.4.6.1. UK: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.6.2. UK: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.6.3. UK: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.6.4. UK: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.6.5. UK: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.7. Malaria Vaccines Market - France
      • 10.4.7.1. France: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.7.2. France: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.7.3. France: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.7.4. France: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.7.5. France: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.8. Malaria Vaccines Market - Germany
      • 10.4.8.1. Germany: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.8.2. Germany: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.8.3. Germany: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.8.4. Germany: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.8.5. Germany: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.9. Malaria Vaccines Market - Italy
      • 10.4.9.1. Italy: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.9.2. Italy: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.9.3. Italy: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.9.4. Italy: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.9.5. Italy: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.10. Malaria Vaccines Market - Spain
      • 10.4.10.1. Spain: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.10.2. Spain: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.10.3. Spain: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.10.4. Spain: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.10.5. Spain: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.11. Malaria Vaccines Market - Netherlands
      • 10.4.11.1. Netherlands: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.11.2. Netherlands: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.11.3. Netherlands: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.11.4. Netherlands: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.11.5. Netherlands: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.12. Malaria Vaccines Market - Russia
      • 10.4.12.1. Russia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.12.2. Russia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.12.3. Russia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.12.4. Russia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.12.5. Russia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.4.13. Malaria Vaccines Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.4.13.2. Rest of Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.4.13.3. Rest of Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.4.13.4. Rest of Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.4.13.5. Rest of Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.5. Malaria Vaccines Market - Asia Pacific
    • 10.5.1. Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.5.2. Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.5.3. Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.5.4. Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.5.5. Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.6. Malaria Vaccines Market - China
      • 10.5.6.1. China: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.6.2. China: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.6.3. China: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.6.4. China: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.6.5. China: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.7. Malaria Vaccines Market - India
      • 10.5.7.1. India: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.7.2. India: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.7.3. India: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.7.4. India: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.7.5. India: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.8. Malaria Vaccines Market - Malaysia
      • 10.5.8.1. Malaysia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.8.2. Malaysia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.8.3. Malaysia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.8.4. Malaysia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.8.5. Malaysia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.9. Malaria Vaccines Market - Japan
      • 10.5.9.1. Japan: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.9.2. Japan: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.9.3. Japan: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.9.4. Japan: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.9.5. Japan: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.10. Malaria Vaccines Market - Indonesia
      • 10.5.10.1. Indonesia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.10.2. Indonesia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.10.3. Indonesia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.10.4. Indonesia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.10.5. Indonesia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.11. Malaria Vaccines Market - South Korea
      • 10.5.11.1. South Korea: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.11.2. South Korea: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.11.3. South Korea: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.11.4. South Korea: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.11.5. South Korea: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.12. Malaria Vaccines Market - Australia
      • 10.5.12.1. Australia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.12.2. Australia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.12.3. Australia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.12.4. Australia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.12.5. Australia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.5.13. Malaria Vaccines Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.5.13.2. Rest of Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.5.13.3. Rest of Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.5.13.4. Rest of Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.5.13.5. Rest of Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.6. Malaria Vaccines Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.6.2. Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.6.3. Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.6.4. Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.6.5. Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.6. Malaria Vaccines Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.6.2. Saudi Arabia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.6.3. Saudi Arabia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.6.4. Saudi Arabia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.6.5. Saudi Arabia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.7. Malaria Vaccines Market - UAE
      • 10.6.7.1. UAE: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.7.2. UAE: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.7.3. UAE: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.7.4. UAE: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.7.5. UAE: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.8. Malaria Vaccines Market - Israel
      • 10.6.8.1. Israel: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.8.2. Israel: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.8.3. Israel: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.8.4. Israel: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.8.5. Israel: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.9. Malaria Vaccines Market - South Africa
      • 10.6.9.1. South Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.9.2. South Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.9.3. South Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.9.4. South Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.9.5. South Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.6.10. Malaria Vaccines Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.6.10.2. Rest of Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.6.10.3. Rest of Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.6.10.4. Rest of Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.6.10.5. Rest of Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • 10.7. Malaria Vaccines Market - Latin America
    • 10.7.1. Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
    • 10.7.2. Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
    • 10.7.3. Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
    • 10.7.4. Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
    • 10.7.5. Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.6. Malaria Vaccines Market - Mexico
      • 10.7.6.1. Mexico: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.6.2. Mexico: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.6.3. Mexico: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.6.4. Mexico: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.6.5. Mexico: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.7. Malaria Vaccines Market - Brazil
      • 10.7.7.1. Brazil: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.7.2. Brazil: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.7.3. Brazil: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.7.4. Brazil: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.7.5. Brazil: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.8. Malaria Vaccines Market - Argentina
      • 10.7.8.1. Argentina: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.8.2. Argentina: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.8.3. Argentina: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.8.4. Argentina: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.8.5. Argentina: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
    • 10.7.9. Malaria Vaccines Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
      • 10.7.9.2. Rest of Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
      • 10.7.9.3. Rest of Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
      • 10.7.9.4. Rest of Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
      • 10.7.9.5. Rest of Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Instituto Butantan
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Merck
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. PATH
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. GSK
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Vaxart
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Biovac
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Pfizer
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Inovio Pharmaceuticals
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Bharat Biotech
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. University of Oxford
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Intellia Therapeutics
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Johnson & Johnson
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Sanaria
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
  • 12.14. Takeda Pharmaceutical Company
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Benchmarking
    • 12.14.4. Recent Development

List of Tables:

  • Table 1 Global Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 2 Global Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 3 Global Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 4 Global Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 5 Global Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 6 North America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 7 North America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 8 North America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 9 North America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 10 North America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 11 US: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 12 US: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 13 US: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 14 US: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 15 US: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 16 Canada: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 17 Canada: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 18 Canada: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 19 Canada: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 20 Canada: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 21 Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 22 Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 23 Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 24 Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 25 Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 26 UK: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 27 UK: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 28 UK: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 29 UK: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 30 UK: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 31 France: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 32 France: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 33 France: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 34 France: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 35 France: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 36 Germany: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 37 Germany: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 38 Germany: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 39 Germany: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 40 Germany: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 41 Italy: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 42 Italy: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 43 Italy: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 44 Italy: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 45 Italy: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 46 Spain: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 47 Spain: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 48 Spain: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 49 Spain: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 50 Spain: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 51 Netherlands: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 52 Netherlands: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 53 Netherlands: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 54 Netherlands: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 55 Netherlands: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 56 Russia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 57 Russia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 58 Russia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 59 Russia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 60 Russia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 61 Rest of Europe: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 62 Rest of Europe: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 63 Rest of Europe: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 64 Rest of Europe: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 65 Rest of Europe: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 66 Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 67 Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 68 Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 69 Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 70 Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 71 China: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 72 China: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 73 China: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 74 China: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 75 China: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 76 India: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 77 India: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 78 India: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 79 India: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 80 India: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 81 Malaysia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 82 Malaysia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 83 Malaysia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 84 Malaysia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 85 Malaysia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 86 Japan: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 87 Japan: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 88 Japan: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 89 Japan: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 90 Japan: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 91 Indonesia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 92 Indonesia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 93 Indonesia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 94 Indonesia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 95 Indonesia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 96 South Korea: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 97 South Korea: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 98 South Korea: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 99 South Korea: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 100 South Korea: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 101 Australia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 102 Australia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 103 Australia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 104 Australia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 105 Australia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 106 Rest of Asia Pacific: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 107 Rest of Asia Pacific: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 108 Rest of Asia Pacific: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 109 Rest of Asia Pacific: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 110 Rest of Asia Pacific: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 111 Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 112 Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 113 Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 114 Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 115 Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 116 Saudi Arabia: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 117 Saudi Arabia: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 118 Saudi Arabia: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 119 Saudi Arabia: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 120 Saudi Arabia: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 121 UAE: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 122 UAE: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 123 UAE: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 124 UAE: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 125 UAE: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 126 Israel: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 127 Israel: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 128 Israel: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 129 Israel: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 130 Israel: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 131 South Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 132 South Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 133 South Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 134 South Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 135 South Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 136 Rest of Middle East & Africa: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 137 Rest of Middle East & Africa: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 138 Rest of Middle East & Africa: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 139 Rest of Middle East & Africa: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 140 Rest of Middle East & Africa: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 141 Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 142 Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 143 Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 144 Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 145 Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 146 Mexico: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 147 Mexico: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 148 Mexico: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 149 Mexico: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 150 Mexico: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 151 Brazil: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 152 Brazil: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 153 Brazil: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 154 Brazil: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 155 Brazil: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 156 Argentina: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 157 Argentina: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 158 Argentina: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 159 Argentina: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 160 Argentina: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)
  • Table 161 Rest of Latin America: Malaria Vaccines Market, by Vaccine Type, 2020-2034 (USD Million)
  • Table 162 Rest of Latin America: Malaria Vaccines Market, by Administration Route, 2020-2034 (USD Million)
  • Table 163 Rest of Latin America: Malaria Vaccines Market, by Target Population, 2020-2034 (USD Million)
  • Table 164 Rest of Latin America: Malaria Vaccines Market, by Immunization Schedule, 2020-2034 (USD Million)
  • Table 165 Rest of Latin America: Malaria Vaccines Market, by Development Stage, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Malaria Vaccines Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Vaccine Type
  • Figure 7. Global Malaria Vaccines Market, by Vaccine Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Administration Route
  • Figure 9. Global Malaria Vaccines Market, by Administration Route, 2024 & 2034 (USD Million)
  • Figure 10. Market by Target Population
  • Figure 11. Global Malaria Vaccines Market, by Target Population, 2024 & 2034 (USD Million)
  • Figure 12. Market by Immunization Schedule
  • Figure 13. Global Malaria Vaccines Market, by Immunization Schedule, 2024 & 2034 (USD Million)
  • Figure 14. Market by Development Stage
  • Figure 15. Global Malaria Vaccines Market, by Development Stage, 2024 & 2034 (USD Million)